Advances in Breast Cancer: From Molecular Science to Patients in the Clinic

Join SciSoc in this panel event held together with Cambridge Pink Week! We welcome Professor Anees Chagpar from Yale University and Professor Carlos Cardas from CRUK Cambridge Institute as they discuss breast cancer in both the clinic and the lab. This talk is open to all regardless of membership.

Register your interest here.

Donate to Pink Week and support the fight against breast cancer here.

16:00-16:30 – Advances in surgery and other treatments for breast cancer (Prof Anees Chagpar)
16:30-17:00 – Redefining breast cancer as a constellation of distinct molecular entities (Professor Carlos Cardas)
17:00-17:30 – Panel

Advances in surgery and other treatments for breast cancer
Prof Anees Chagpar
MD, MBA, MPH, FACS, FRCS(C)
Professor in the Department of Surgery at Yale School of Medicine

Professor Anees Chagpar is a Professor in the Department of Surgery at Yale School of Medicine. Following completion of her residency and fellowship, she joined the University of Louisville as Assistant Professor of Surgery, rising rapidly to Associate Professor with tenure and Academic Advisory Dean. She built the first nationally accredited Breast Center in Kentucky at the James Graham Brown Cancer Center, before being recruited to Yale in 2010 where she led the effort for Yale to become the first National Cancer Institute (NCI)-designated Comprehensive Cancer Center in the Northeast to have a nationally accredited breast center. Professor Chagpar will be talking about how breast cancer treatment (particularly surgery) has changed over the past several decades, and how it might change in the future. She will also cover landmark clinical trials, and how these have shaped what clinicians do.

Redefining breast cancer as a constellation of distinct molecular entities
Prof Carlos Caldas
MD FACP FRCP FRCPath FMedSci
Professor of Cancer Medicine, University of Cambridge
Senior Group Leader, Cancer Research UK Cambridge Institute

Professor Carlos Caldas is a Professor of Cancer Medicine at the University of Cambridge, and Senior Group Leader of the Breast Cancer Functional Genomics Laboratory at the Cancer Research UK Cambridge Institute. He is a Fellow of the Academy of the Medical Sciences, Fellow of the European Academy of Cancer Sciences, and EMBO Member. He has published over 400 manuscripts, including Nature, Cell, New England Journal of Medicine and many more. His laboratory defined the molecular taxonomy of breast cancer, revealing novel subtypes and their respective drivers. He showed that this new breast cancer classification determines the clinical trajectories of patients, including their risk for late relapse. Professor Caldas will talk about his research focus on the functional genomics of breast cancer, and its biological and clinical implications.